MAR 07, 2018 12:52 PM PST

New Diagnostic Test for Zika Virus Extends Detection Window

WRITTEN BY: Kara Marker

Diagnostic tests for the Zika virus are only reliable in the three weeks following initial infection. That is, until now. Researchers from Columbia University developed a new diagnostic test that can detect the virus in the bloodstream several months after a person is infected.

Credit: Columbia University's Mailman School of Public Health

The new Zika test improvements are threefold: better accuracy, quicker results, and enhanced cost-effectiveness. Better diagnostic capabilities are particularly vital for pregnant women, whose unborn babies run the risk of neurodevelopmental problems. For example, the Zika virus can cause the development of Guillain-Barre syndrome, an autoimmune disease affecting the nervous system.

"Many people infected by Zika have only mild illness, or are unable to see a clinician in the early, acute phase of infection," explained lead author Nischay Mishra, PhD. "Our new test greatly extends the window during which an individual can be assessed with accuracy."

The Zika virus, which was first discovered in monkeys in Uganda in 1947, is transmitted through the bite of a particular species of mosquito, the same species that is responsible for spreading dengue fever and yellow fever. No vaccine or cure exists for the Zika virus.

"An affordable and accurate test for Zika virus is critical for public health," said senior author W. Ian Lipkin, MD. "Even absent symptoms of illness or evidence of birth defects, Zika may inflict long-term harm on the person infected or their offspring."

Existing molecular tests for the Zika virus can reliably detect the virus circulating in the bloodstream two to three weeks after a person is first infected. In addition to the time limitation, existing tests also run the risk of producing false positive results, as it mistakenly recognizes similar viruses such as dengue, yellow fever, and Japanese encephalitis.

The new test, “ZIKV-NS2B-concat ELISA,” overcomes the limitations of its predecessors. The test is a customized version of ELISA, which recognizes peptide sequences that uniquely bind to antibodies produced by the body in response to the Zika virus. Researchers tested the tests efficacy with a blood sample analysis, obtained from children who had previously tested positive for Zika virus via traditional methods.

The test proved to be specific, sensitive, and reliable. False positive and false negative results occurred less than five percent of the time when the test was done within the first few weeks after acute illness. Additionally, the test can accurately analyze up to 200 samples in four hours.

The present study was published in the journal mBio.

Sources: Centers for Disease Control and Prevention, World Health Organization, Columbia University’s Mailman School of Public Health

About the Author
  • I am a scientific journalist and enthusiast, especially in the realm of biomedicine. I am passionate about conveying the truth in scientific phenomena and subsequently improving health and public awareness. Sometimes scientific research needs a translator to effectively communicate the scientific jargon present in significant findings. I plan to be that translating communicator, and I hope to decrease the spread of misrepresented scientific phenomena! Check out my science blog: ScienceKara.com.
You May Also Like
OCT 24, 2020
Clinical & Molecular DX
Software Flags Elevated Cerebral Palsy Risk in Premies
OCT 24, 2020
Software Flags Elevated Cerebral Palsy Risk in Premies
Diagnostic imaging scientists have developed a software tool for predicting the future onset of cerebral palsy in babies ...
DEC 02, 2020
Clinical & Molecular DX
Digital Platform Watches for a Silent COVID Killer
DEC 02, 2020
Digital Platform Watches for a Silent COVID Killer
 
DEC 24, 2020
Clinical & Molecular DX
Feeling Unmotivated? It Could Be Dementia.
DEC 24, 2020
Feeling Unmotivated? It Could Be Dementia.
Apathy, characterized by a pronounced lack of enthusiasm, motivation, or interest, is a predictor of the future onset of ...
JAN 01, 2021
Genetics & Genomics
Common Brain Disorder Has a Genetic Influence
JAN 01, 2021
Common Brain Disorder Has a Genetic Influence
It's thought that as many as one in one hundred people are born with a brain disorder known as Chiari 1 malformation, bu ...
FEB 02, 2021
Clinical & Molecular DX
Keeping an Eye on COVID Clusters With Rapid Sequencing
FEB 02, 2021
Keeping an Eye on COVID Clusters With Rapid Sequencing
Contact tracing is a powerful tool used by public health authorities to help slow the spread of infectious diseases such ...
FEB 11, 2021
Clinical & Molecular DX
Seeing if Hormone Therapy Will Work for Breast Cancer Patients
FEB 11, 2021
Seeing if Hormone Therapy Will Work for Breast Cancer Patients
Only around half of women diagnosed with breast cancer will benefit from hormonal therapy, a cancer treatment that adds, ...
Loading Comments...